Kaipainen, Tarja
Hartikainen, Sirpa
Tiihonen, Miia
Nykänen, Irma
Funding for this research was provided by:
The Northern Savo Regional Fund
Article History
Received: 28 May 2021
Accepted: 25 April 2022
First Online: 4 May 2022
Declarations
:
: The study protocol was approved by the Research Ethics Committee of the Northern Savo Hospital District, Kuopio, Finland. All participants or their legal guardians received oral and written information about all stages of the study, as well as the right to withdraw from the study. The participants or their legal guardians gave written informed consent. All procedures were carried out in accordance with the 1964 Helsinki Declaration and its later amendments. Legal guardian(s) in the ‘ethics approval and consent to participate.
: Not applicable.
: SH has got a lectures fee from Astellas Pharma. The other authors declare that they have no competing interests.